OBJECTIVE -We studied the association of maximum oxygen uptake (Vo 2max ) with the development and resolution of metabolic syndrome (MetS) for 2 years in older individuals.
C
ross-sectional population studies have shown an inverse association between cardiorespiratory fitness (CRF) and the metabolic syndrome (MetS) in middle-aged and older men and women (1, 2) . There are few prospective population studies on the association between CRF and the development of MetS (3) (4) (5) (6) and no such studies on the resolution of MetS. None of these studies have been conducted in older men and women. Evidence of the association between changes in CRF and metabolic risk rely on relatively small prospective studies among middle-aged or high-risk individuals (6,7). We therefore studied the association of maximum oxygen uptake (Vo 2max ) with the development and resolution of MetS and changes in Vo 2max and metabolic risk in a population sample of older men and women.
RESEARCH DESIGN AND METHODS -We used baseline and 2-year follow-up data of an ongoing randomized controlled trial, the Dose Responses to Exercise Training (DR's EXTRA) study, which includes five intervention groups and one control group (2) . After excluding individuals with diabetes or incomplete data, analyses consisted of 589 men and 637 women aged 57-78 years.
CRF was assessed by a respiratory gas analysis during a maximum symptomlimited exercise test on a cycle ergometer (2) . Physical activity was assessed by a questionnaire, and dietary intake was assessed by a 4-day food record including 3 weekdays and 1 weekend day. MetS was defined by the National Cholesterol Education Program (NCEP) criteria (8), and a metabolic risk score (z-MetS) was constructed (5,7). Other assessments have previously been explained (2) .
The associations of baseline Vo 2max with the development and resolution of MetS during 2 years were analyzed using logistic regression analysis (n ϭ 1,137) and the 2-year associations of Vo 2max with z-MetS and features of MetS by linear mixed models (n ϭ 1,226). Statistical analyses were performed using SPSS.
RESULTS -At baseline, 22% of men and women had MetS. Of 427 men and 466 women without MetS at baseline, 44 and 49, respectively, developed it during 2 years. Of 117 men and 127 women with MetS at baseline, 47 and 38, respectively, resolved it during 2 years.
Among individuals without MetS at baseline, 1-SD higher baseline Vo 2max (men 6.1, women 4.8 ml ⅐ kg Ϫ1 ⅐ min
Ϫ1
) was associated with a 44% (95% CI 24 -58) decreased risk of developing MetS during 2 years in all individuals; a 56% (27-73) decreased risk in men; and a 35% (4 -56) decreased risk in women adjusted for age, smoking, alcohol consumption, cardiovascular diseases, NCEP metabolic risk sum, and study groups at baseline. Individuals in the highest sex-specific third of baseline Vo 2max were 68% less likely to develop MetS than those in the lowest third (Table 1) . Further adjustments for physical activity and dietary intakes (saturated, monounsaturated, and polyunsaturated fatty acids, fiber, and carbohydrates) at baseline and study groups did not affect the association, but adjustment for body weight at baseline and changes in body weight during 2 years diminished it.
Among individuals with MetS at baseline, 1-SD higher Vo 2max was associated with a 1.8 (1.21-2.82) times higher likelihood to resolve MetS during 2 years in all individuals; a 2.1 (1.12-3.96) times
higher likelihood in men; and a 1.9 (0.98 -3.70) times higher likelihood in women after baseline adjustments. Individuals in the highest third of Vo 2max were 3.9 times more likely to resolve MetS than those in the lowest third (Table 1) . Further adjustments slightly strengthened the association.
One ml ⅐ kg Ϫ1 ⅐ min Ϫ1 increase in Vo 2max was associated with a 0.19 unit (95% CI Ϫ0.17 to Ϫ0.21) reduction in z-MetS adjusted for age, sex, and study groups. Further adjustment for smoking, alcohol consumption, use of lipidlowering and antihypertensive medication, cardiovascular diseases, physical activity, and dietary intakes during 2 years did not materially change the association. One ml ⅐ kg Ϫ1 ⅐ min Ϫ1 increase in Vo 2max was also associated with a reduction in waist circumference (␤ ϭ Ϫ0.47, P Ͻ 0.001), fasting glucose (␤ ϭ Ϫ0.02, P Ͻ 0.001), triglycerides (␤ ϭ Ϫ0.03, P Ͻ 0.001), systolic blood pressure (␤ ϭ Ϫ0.29, P ϭ 0.001), diastolic blood pressure (␤ ϭ Ϫ0.20, P Ͻ 0.001), and an increase in HDL cholesterol (␤ ϭ 0.02, P Ͻ 0.001) after adjustments for age, sex, and study groups.
CONCLUSIONS -The present study suggests that higher levels of CRF protect against the development of MetS and may also resolve it over 2 years among older men and women. The most fit individuals were about 70% less likely to develop MetS and four times more likely to resolve it than the least fit individuals. Increased CRF improved the components of MetS and the overall metabolic risk profile during 2 years.
We have previously reported that older men and women in the lowest third of Vo 2max had 10 times higher risk of MetS than the most fit individuals (2) and that higher levels of cardiorespiratory fitness protected against the development of MetS during 4 years in middle-aged men (3). Also, CRF in young adulthood was inversely associated with the risk of developing MetS, type 2 diabetes, and hypertension in middle-age (4). In contrast, no independent association between CRF and the development of MetS was found in middle-aged individuals after controlling for physical activity (5,6). In the present study, the association between CRF and MetS remained after adjustment for physical activity and dietary intakes.
Physical activity is the principal determinant of CRF, although genetic variation, age, and body composition also contribute (9). Middle-aged men who have higher levels of CRF and who are able to maintain good CRF are physically more active and have higher lean body mass and lower body fat mass than those who have worse CRF. These individuals have improved carbohydrate and fat metabolism that can protect against or even resolve MetS (10).
The study population included a large number of older men and women recruited from the national population register. We assessed Vo 2max directly by respiratory gas analysis during a maximum exercise test, which is the most accurate measure of CRF. While most other studies have only focused on the incidence of MetS, we studied the incidence and resolution of MetS. We also used a continuous metabolic risk score as an outcome variable to increase statistical power to detect true associations.
In conclusion, the present study emphasizes CRF as a predictor of cardiometabolic health in older individuals with and without MetS. 
